A novel OSMR mutation in familial primary localized cutaneous amyloidosis in a Japanese family

Journal of Dermatological Science

Volumn 55, Issue 1, 2009, Pages 64-65

  Arita, Ken ^a   Abe, Riichiro ^a   Baba, Keiko ^a   McGrath, John A ^b   Akiyama, Masashi ^a   Shimizu, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Fibronectin III like domain; Lichen amyloidosis; Oncostatin M receptor

Indexed keywords

ONCOSTATIN M RECEPTOR BETA;

ADULT; AMYLOIDOSIS; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; HUMAN; LETTER; MUTATIONAL ANALYSIS; MUTATOR GENE; NUCLEOTIDE SEQUENCE; ONCOSTATIN M RECEPTOR BETA GENE; PAPULE; PRIMARY LOCALIZED SKIN AMYLOIDOSIS; PRIORITY JOURNAL; SKIN DISEASE; SKIN MANIFESTATION;

ADULT; AMYLOIDOSIS, FAMILIAL; FEMALE; HUMANS; JAPAN; MIDDLE AGED; MUTATION; ONCOSTATIN M RECEPTOR BETA SUBUNIT; PEDIGREE; SKIN DISEASES;

EID: 67349085829     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2009.03.003     Document Type: Letter

References (13)

1. Kumakiri M., and Hashimoto K. Histogenesis of primary localized cutaneous amyloidosis: sequential change of epidermal keratinocytes to amyloid via filamentous degeneration. J Invest Dermatol 73 (1979) 150-162
2. Kobayashi H., and Hashimoto K. Amyloidogenesis in organ-limited cutaneous amyloidosis: an antigenic identity between epidermal keratin and skin amyloid. J Invest Dermatol 80 (1983) 66-72
3. Arita K., South A.P., Hans-Filho G., Sakuma T.H., Lai-Cheong J., Clements S., et al. Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis. Am J Hum Genet 82 (2008) 73-80
4. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., and Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374 (2003) 1-20
5. Dillon S.R., Sprecher C., Hammond A., Bilsborough J., Rosenfeld-Franklin M., Presnell S.R., et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 5 (2004) 752-760
6. Finelt N., Gazel A., Gorelick S., and Blumenberg M. Transcriptional responses of human epidermal keratinocytes to oncostatin-M. Cytokine 31 (2005) 305-313
7. Boniface K., Diveu C., Morel F., Pedretti N., Froger J., Ravon E., et al. Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation. J Immunol 178 (2007) 4615-4622
8. Kurth I., Horsten U., Pflanz S., Timmermann A., Kuster A., Dahmen H., et al. Importance of the membrane-proximal extracellular domains for activation of the signal transducer glycoprotein 130. J Immunol 164 (2000) 273-282
9. Timmermann A., Küster A., Kurth I., Heinrich P.C., and Müller-Newen G. A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor. Eur J Biochem 269 (2002) 2716-2726
10. Chen R.H., Chang M.C., Su Y.H., Tsai Y.H., and Kuo M.L. Interleukin-6 inhibits transforming growth factor beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J Biol Chem 274 (1999) 23013-23019
11. Mirmohammadsadegh A., Mota R., Gustrau A., Hassan M., Nambiar S., Marini A., et al. ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis. J Invest Dermatol 127 (2007) 2207-2215
12. Maddison B., Namazi M.R., Samuel L.S., Sanchez J., Pichardo R., Stocks J., et al. Unexpected diminished innervation of epidermis and dermoepidermal junction in lichen amyloidosis. Br J Dermatol 159 (2008) 403-406
13. Bando T., Morikawa Y., Komori T., and Senba E. Complete overlap of interleukin 31 receptor A and oncostatin M receptor beta in the adult dorsal root ganglia with distinct developmental expression pattern. Neuroscience 142 (2006) 1263-1271